|
| |
| | | 66152 | | 23.05.2017 | | Roche Pharma (Schweiz) AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Tecentriq 1200 mg/20 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Atezolizumabum 1200mg / 20ml) | L01FF05 | | | 02 | Tecentriq 840 mg/14 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Atezolizumabum 840mg / 14ml) | L01FF05 | |
|
|
|
